Cargando…
Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients
BACKGROUND: Although deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a highly effective therapeutic intervention in severe Parkinson's disease, its mechanism of action remains unclear. One possibility is that DBS suppresses local pathologically synchronised oscillatory activity...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072048/ https://www.ncbi.nlm.nih.gov/pubmed/20935326 http://dx.doi.org/10.1136/jnnp.2010.217489 |
_version_ | 1782201500196405248 |
---|---|
author | Eusebio, A Thevathasan, W Doyle Gaynor, L Pogosyan, A Bye, E Foltynie, T Zrinzo, L Ashkan, K Aziz, T Brown, P |
author_facet | Eusebio, A Thevathasan, W Doyle Gaynor, L Pogosyan, A Bye, E Foltynie, T Zrinzo, L Ashkan, K Aziz, T Brown, P |
author_sort | Eusebio, A |
collection | PubMed |
description | BACKGROUND: Although deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a highly effective therapeutic intervention in severe Parkinson's disease, its mechanism of action remains unclear. One possibility is that DBS suppresses local pathologically synchronised oscillatory activity. METHODS: To explore this, the authors recorded from DBS electrodes implanted in the STN of 16 patients with Parkinson's disease during simultaneous stimulation (pulse width 60 μs; frequency 130 Hz) of the same target using a specially designed amplifier. The authors analysed data from 25 sides. RESULTS: The authors found that DBS progressively suppressed peaks in local field potential activity at frequencies between 11 and 30 Hz as voltage was increased beyond a stimulation threshold of 1.5 V. Median peak power had fallen to 54% of baseline values by a stimulation intensity of 3.0 V. CONCLUSION: The findings suggest that DBS can suppress pathological 11–30 Hz activity in the vicinity of stimulation in patients with Parkinson's disease. This suppression occurs at stimulation voltages that are clinically effective. |
format | Text |
id | pubmed-3072048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BMJ Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-30720482011-04-18 Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients Eusebio, A Thevathasan, W Doyle Gaynor, L Pogosyan, A Bye, E Foltynie, T Zrinzo, L Ashkan, K Aziz, T Brown, P J Neurol Neurosurg Psychiatry Research Paper BACKGROUND: Although deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a highly effective therapeutic intervention in severe Parkinson's disease, its mechanism of action remains unclear. One possibility is that DBS suppresses local pathologically synchronised oscillatory activity. METHODS: To explore this, the authors recorded from DBS electrodes implanted in the STN of 16 patients with Parkinson's disease during simultaneous stimulation (pulse width 60 μs; frequency 130 Hz) of the same target using a specially designed amplifier. The authors analysed data from 25 sides. RESULTS: The authors found that DBS progressively suppressed peaks in local field potential activity at frequencies between 11 and 30 Hz as voltage was increased beyond a stimulation threshold of 1.5 V. Median peak power had fallen to 54% of baseline values by a stimulation intensity of 3.0 V. CONCLUSION: The findings suggest that DBS can suppress pathological 11–30 Hz activity in the vicinity of stimulation in patients with Parkinson's disease. This suppression occurs at stimulation voltages that are clinically effective. BMJ Group 2010-10-09 2011-05 /pmc/articles/PMC3072048/ /pubmed/20935326 http://dx.doi.org/10.1136/jnnp.2010.217489 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Research Paper Eusebio, A Thevathasan, W Doyle Gaynor, L Pogosyan, A Bye, E Foltynie, T Zrinzo, L Ashkan, K Aziz, T Brown, P Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
title | Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
title_full | Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
title_fullStr | Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
title_full_unstemmed | Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
title_short | Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
title_sort | deep brain stimulation can suppress pathological synchronisation in parkinsonian patients |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072048/ https://www.ncbi.nlm.nih.gov/pubmed/20935326 http://dx.doi.org/10.1136/jnnp.2010.217489 |
work_keys_str_mv | AT eusebioa deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT thevathasanw deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT doylegaynorl deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT pogosyana deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT byee deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT foltyniet deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT zrinzol deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT ashkank deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT azizt deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients AT brownp deepbrainstimulationcansuppresspathologicalsynchronisationinparkinsonianpatients |